 | Up a level |
Number of items: 1.
Faehling, M., Schumann, C., Christopoulos, P., Hoffknecht, P., Alt, J., Horn, M., Eisenmann, S., Schlenska-Lange, A., Aries, S. P., Sackmann, S., Schuett, P., Steger, F. and Christoph, D. (2020). Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP). Ann. Oncol., 31. S. S806 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041